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Despite subjective functional improvement and improve-ment in quality of life, heart transplant recipientsdemonstrate a persistent reduction in exercise capacity.Central factors, such as cardiac dysfunction and
chronotropic insufficiency, likely participate in this limitation, but
numerous studies underlined the role of peripheral factors.1 Nitric
oxide (NO), mainly produced in the endothelium, is a major com-
ponent involved in both basal and exercise vascular tone, and flow-
mediated release of NO is thought to be important for exercise-
induced vasodilation. Interestingly, an exercise-induced increase in
circulating nitrates and nitrites (NOx), the stable end product
reflecting NO production, has recently been observed and was
associated with physical fitness in healthy human subjects.2,3
Furthermore, supplementation with the NO precursor L-arginine
enhanced endothelium-dependant vasodilation and exercise capac-
ity in patients with heart failure.4 We therefore investigated
whether impaired NO release might participate in exercise limita-
tion after heart transplantation.
Method and Results
Plasma NOx values were determined by the colorimetric method
on the basis of the Griess reaction before, at 70% of peak, at peak,
and at 10, 30, and 60 minutes of recovery during a graded maximal
bicycle exercise in 8 heart transplant recipients and 8 age- and
weight-matched healthy control subjects. All subjects were in
sinus rhythm and free of cardiac symptoms. The mean time
elapsed since transplantation was 3 years, and heart transplant
recipients, free of rejection, were undergoing their usual triple
immunosuppressive therapy. The study was approved by the uni-
versity review board for human studies, and each subject gave
informed consent.
As expected, exercise capacity was reduced in heart transplant
recipients (123 ± 12 vs 199 ± 14 W, P < .001). Resting plasma
NOx values were increased after heart transplantation compared
with normal values (56.3 ± 12.5 vs 27.0 ± 3.7 µmol/L, P = .04).
Exercise increased plasma NOx values significantly in control sub-
jects (+17.1% ± 5.6% [P < .005] and +19.4% ± 6.7% [P < .02] at
10 and 30 minutes of recovery, respectively), but plasma NOx val-
ues failed to change significantly in heart transplant recipients
(Figure 1). Furthermore, confirming previous data,3 a positive cor-
relation was observed between both resting (r = 0.96, P < .001) and
peak exercise (r = 0.95, P < .001) plasma NOx values and maxi-
mal power in healthy subjects. Such a relationship was lacking
after heart transplantation (Figure 2).
Discussion
This study confirms that plasma NOx values increase during max-
imal exercise in healthy subjects and demonstrates for the first time
that reduced exercise capacity is associated with reduced NO pro-
duction, together with a loss of the NO-exercise capacity relation-
ship after heart transplantation.
Previous studies demonstrated that exercise increases NOx, the
release of which is stimulated by various local and circulating factors.
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Figure 1. Time course of NOx changes in response to maximal
ergocycle exercise in healthy subjects (open bars) and in heart
transplant recipients (filled bars). 70%-Re, Submaximal exercise
at 70% maximum oxygen consumption minus rest; Peak-Re, peak
exercise minus rest; R10, R30, and R60-Re, 10, 30, and 60 minutes
recovery minus rest. *P < .05.
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The most important is shear stress, likely explaining exercise-induced
NOx elevation in healthy subjects.2,3 Although submitted to a similar
hemodynamic stimulus, NOx values failed to increase in response to
maximal exercise in heart transplant recipients. Several explanations
may be proposed. First, according to previous data, resting NOx val-
ues were increased after heart transplantation compared with normal
values.5 Such elevation might subsequently reduce the ability of heart
transplant recipients to further stimulate their NO pathway. This is
nevertheless unlikely because increases of transient NOx values have
been reported during rejection in heart transplant recipients.5
Alternatively, exercise-induced NO production could be masked by a
simultaneous enhancement in renal NO excretion after heart trans-
plantation. Indeed, short-lasting plasma NOx variations result from
both NO production and catabolism. Nevertheless, NO renal excre-
tion is unmodified during exercise in normal subjects,3 and if any
effect, exercise should decrease NO renal excretion in heart trans-
plant recipients in view of their greater decrease in renal blood flow
at peak exercise. Thus, the lack of increase of NOx values in response
to exercise after heart transplantation appears mainly related to an
impaired NO production.
As in heart failure, peripheral factors are important determi-
nants of exercise capacity after heart transplantation.1,4
Particularly, peripheral vasoconstriction with reduced exercise-
induced hyperemia to working muscles may be linked to endothe-
lial dysfunction. Accordingly, heart transplant recipients not only
present with an attenuated response to the endothelium-dependent
vasodilator acetylcholine, but their impaired endothelial response
closely correlates with their exercise capacity.1 Our data support
that besides an impaired endothelium-dependent vasodilation, a
reduced endogenous NO production likely contributes to the lower
peak exercise reached after heart transplantation. These mecha-
nisms might lead to inadequate relaxation of smooth muscle in
small arterioles and hypoperfusion to exercising muscles, explain-
ing the loss of NOx-exercise capacity relationship observed after
heart transplantation. 
In summary, further expanding our comprehension of exercise
limitation, we observed that besides the attenuated endothelium-
dependant vasodilation of the microcirculation, reduced NO pro-
duction might contribute to reduced exercise capacity in heart
transplant recipients. This suggests the usefulness of studies inves-
tigating the effect of NO pathway stimulation on exercise capacity
after heart transplantation.
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Figure 2. Relationship between resting plasma NOx values and
maximal power in control subjects (open circles) and heart trans-
plant recipients (filled circles).
